AIMD

8-K - Ainos, Inc. (0001014763) (Filer)

Partner's Written Confirmation Fulfills Payment Conditions; Initial License Fee Payable Within 15 Business Days HOUSTON, TX / ACCESS Newswire / September 30, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it has completed the required data delivery and technology transfer under its VELDONA® license agreement, triggering a $600,000 initial license payment. The licensing partner confirmed completion in writing on September 29. Payment is due within 15 business days under the agreement.The delivery includes clinical and regulatory materials for Sjögren's disease and thrombocytopenia, providing a foundation for the partner's continued develop

Preparations underway for a larger-scale second-phase deployment specified in the existing MOU, building on first-phase deployment experienceAdvanced packaging deployment marks a major step for Ainos' Chemical Intelligence platform, alongside commercial progress in advanced wafer fabrication HOUSTON, TX / ACCESS Newswire / September 29, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it has completed delivery of all 1,400 AI Nose systems to ASE Technology Holding Co., Ltd. ("ASE") under the announced $2.1 million, three-year agreement. The completed delivery marks a major commercial milestone for Ainos' Chemical Intelligence platform in ad

8-K - Ainos, Inc. (0001014763) (Filer)

Initial license payment tied to near-term contractual delivery; additional payment opportunities may arise during development, before drug approvalPartner assumes assigned clinical and regulatory funding and execution, reducing Ainos' independent capital and staffing requirementsAinos retains existing platform ownership and 25% of applicable net sublicensing revenue; potential economic participation extends beyond the $10 million licensing framework HOUSTON, TX / ACCESS Newswire / September 28, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today detailed the financial and strategic benefits of the VELDONA® License Agreement announced on September 24, 2026 (t

Partner-funded development marks an important milestone for VELDONA, with BioPhoenix funding and advancing clinical and regulatory development for two initial indicationsDevelopment funding is additional to the framework; Ainos retains core platform ownership, product supply opportunities and contractual participation in downstream commercial revenue HOUSTON, TX / ACCESS Newswire / September 24, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it has entered into a VELDONA® License Agreement with BioPhoenix Co., Ltd. ("BioPhoenix"), establishing a collaboration framework with a potential aggregate value of $10 million. The framework compris

Report points to front-end semiconductor orders, a $2.1 million back-end program and continued dataset expansion as key indicators of Ainos' growing commercial scale Report points to front-end semiconductor orders, a $2.1 million back-end program and continued dataset expansion as key indicators of Ainos' growing commercial scale HOUSTON, TX / ACCESS Newswire / September 16, 2026 / Ainos, Inc. (NASDAQ:AIMD, AIMDW)) ("Ainos" or the "Company") today highlighted a new research update from VASRO GmbH that points to strengthening commercial momentum for Ainos' AI Nose platform across semiconductor applications, supported by initial front-end orders, an established back-end subscription prog

Initial commercial orders mark progress toward broader commercial adoption and support revenue-generation opportunities beginning in 2H 2026Proprietary real-world chemical dataset surpasses 1 billion records, strengthening Ainos' Chemical Intelligence foundation Initial commercial orders mark progress toward broader commercial adoption and support revenue-generation opportunities beginning in 2H 2026Proprietary real-world chemical dataset surpasses 1 billion records, strengthening Ainos' Chemical Intelligence foundation HOUSTON, TX / ACCESS Newswire / September 14, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that its second-generation AI No

New patents cover electronic nose integration with robotics, expanding Ainos' portfolio of 124 patent assets worldwide across chips, sensing architectures, chemical molecules and real-world applications New patents cover electronic nose integration with robotics, expanding Ainos' portfolio of 124 patent assets worldwide across chips, sensing architectures, chemical molecules and real-world applications HOUSTON, TX / ACCESS Newswire / September 9, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it has secured three new Japanese patents covering AI Nose technologies and their integration with robotic systems.The newly granted patents cover g

High-efficiency, on-site nitrogen generation is designed to protect high-value AI infrastructure, reduce oxidation and environmental degradation, and bring greater flexibility and resilience to semiconductor manufacturing HOUSTON, TX / ACCESS Newswire / August 19, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced the global launch of Atmosphere Engine™, a new platform that extends the Company's capabilities in AI-powered environmental sensing, Chemical Intelligence and smart manufacturing into active environmental management.Atmosphere Engine is designed to generate high-purity nitrogen and oxygen directly from ambient air, on-site and closer to the po

Second-generation platform combines upgraded software, firmware, Edge AI and industrial-grade hardware to support reliable 24/7 real-world deploymentMore than 878 million real-world smell data records strengthen Ainos' Smell Intelligence foundation, with every AI Nose serving as a continuously learning node toward a broader Chemical Intelligence network HOUSTON, TX / ACCESS Newswire / August 17, 2026 / Ainos, Inc. (NASDAQ:AIMD, AIMDW)) ("Ainos" or the "Company"), a pioneer in AI-powered Chemical Intelligence, today announced the next generation of its AI Nose platform, featuring comprehensive upgrades across software, firmware, edge computing and hardware reliability.The second-generation AI

Dataset expands by approximately 265 million data points since July 21 as continued AI Nose system deployment across semiconductor manufacturing environments accelerates Ainos' Real-World Data Flywheel and Chemical Intelligence development HOUSTON, TX / ACCESS Newswire / August 13, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that its AI Nose platform has surpassed 878 million real-world smell and chemical data points, primarily generated from semiconductor manufacturing and real-world operating environments, marking another significant milestone in the Company's development of Chemical Intelligence for Physical AI.Since reporting approximately 61

AI Nose and Atmosphere Engine bring a new layer of environmental perception to intelligent machines HOUSTON, TX / ACCESS Newswire / August 12, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it will showcase its Environmental Intelligence solutions for Physical AI at SEMICON Taiwan 2026, taking place September 2-4. Through AI Nose and Atmosphere Engine, Ainos will demonstrate how Environmental Intelligence can give machines a new way to sense, understand, and ultimately respond to the world around them. The Company will exhibit at Booth I2700 Taipei Nangang Exhibition Hall 1, together with its distribution partner Topco Scientific Co., Ltd.This

HOUSTON, TX / ACCESS Newswire / August 10, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced VASRO GmbH has published a new report discussing Ainos' progress in scaling its AI Nose platform through semiconductor deployments, real-world data accumulation, and commercialization opportunities into the second half of 2026.VASRO notes that AI Nose has accumulated approximately 613 million industrial Smell ID data records since December 2025, primarily from semiconductor manufacturing environments. The report views this rapidly expanding real-world dataset as a core strategic asset that strengthens Ainos' Smell AI capabilities, enhances the platform's abilit

HOUSTON, TX / ACCESS Newswire / August 6, 2026 / Ainos, Inc. (NASDAQ:AIMD, AIMDW)) ("Ainos" or the "Company") today announced that Zacks Small-Cap Research ("Zacks SCR") has published a research report covering Ainos' AI Nose platform and the Company's efforts to develop digital scent intelligence for artificial intelligence applications.The report discusses Ainos' approach to converting airborne chemical signals into structured digital scent data through AI Nose, Smell ID, and the Company's developing Smell Language Model ("SLM"). The report discusses Ainos' efforts to apply Smell AI technology across semiconductor manufacturing, robotics, healthcare infrastructure, and other potential appl

8-K - Ainos, Inc. (0001014763) (Filer)

HOUSTON, TX / ACCESS Newswire / August 3, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced results for the second quarter ended June 30, 2026, and provided a business update on continued execution progress for AI Nose across semiconductor manufacturing, industrial infrastructure, robotics, and healthcare-related environments.Eddy Tsai, Chairman, President and Chief Executive Officer, commented:"We believe AI is increasingly expanding beyond understanding text, images, and speech toward interpreting real-world environmental information. This vision continues to guide Ainos' commercialization strategy for AI Nose. We believe future semiconductor manufac

10-Q - Ainos, Inc. (0001014763) (Filer)

424B5 - Ainos, Inc. (0001014763) (Filer)

AI Nose deployments have generated approximately 613 million industrial scent data points since December 2025, advancing Ainos' vision of a smell intelligence network HOUSTON, TX / ACCESS Newswire / July 21, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in Smell AI, today announced that its AI Nose deployments have generated approximately 613 million industrial scent data points since December 2025, primarily from semiconductor manufacturing environments.The milestone reflects the continued expansion of Ainos' Smell AI platform. AI Nose continuously converts environmental scent patterns into machine-readable data used to create and refine proprietary Sm

8-K - Ainos, Inc. (0001014763) (Filer)

8-K - Ainos, Inc. (0001014763) (Filer)

HOUSTON, TX / ACCESS Newswire / June 22, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a Smell AI company digitizing scent into machine-readable data for artificial intelligence applications, today highlighted a new update report published by VASRO GmbH ("VASRO") reviewing Ainos' planned expansion of its AI Nose platform into patient-level breath intelligence.The VASRO update reviews Ainos' recently announced one-year research program with National Taiwan University, scheduled to begin on July 1, 2026, to evaluate whether AI-analyzed breath patterns may help distinguish acute exacerbations of chronic obstructive pulmonary disease ("COPD") from acute decompensated

Program expands Ainos' Smell AI platform from environmental intelligence into digital breath intelligence for emergency medicine research HOUSTON, TX / ACCESS Newswire / June 17, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent digitization and Smell AI technologies, today announced a new research program with National Taiwan University ("NTU") to explore the use of Smell AI in emergency medicine.The program, titled "Rapid Diagnosis of Dyspneic Patients in the Emergency Department via AI-powered Electronic Nose Technology," will explore the use of Ainos' Smell AI platform to analyze volatile organic compounds ("VOCs") in exhaled breath.

4 - Ainos, Inc. (0001014763) (Issuer)